When a global pharma company decided to expand co-promotional efforts for a blockbuster brand into new markets, it was seeking rapid market entry.

The challenge was clear. In 2005, the pharma company decided to promote a compound internationally, but had a very limited pharmaceutical infrastructure in place across the chosen markets. The decision was to outsource the project in order to achieve a cost-effective, speedy market entry at minimal risk. Quintiles has the on-the-ground resources and regulatory depth to respond to the emerging challenges — and opportunities — of the New Health.